Lineage Cell Therapeutics
LCTX
#8223
Rank
HK$1.25 B
Marketcap
HK$6.65
Share price
1.22%
Change (1 day)
-33.59%
Change (1 year)

Lineage Cell Therapeutics (LCTX) - Total liabilities

Total liabilities on the balance sheet as of June 2024 : HK$0.27 B

According to Lineage Cell Therapeutics 's latest financial reports the company's total liabilities are HK$0.27 B. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Lineage Cell Therapeutics - Total liabilities on balance sheet (from 2001 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-12-31HK$0.30 B-24.64%
2022-12-31HK$0.40 B-38.03%
2021-12-31HK$0.65 B556.19%
2020-12-31HK$99.39 M-10.32%
2019-12-31HK$0.11 B50.34%
2018-12-31HK$73.72 M5.1%
2017-12-31HK$70.14 M-25.02%
2016-12-31HK$93.55 M-33.73%
2015-12-31HK$0.14 B49.45%
2014-12-31HK$94.45 M-21.25%
2013-12-31HK$0.11 B183.7%
2012-12-31HK$42.27 M24.52%
2011-12-31HK$33.95 M13.41%
2010-12-31HK$29.93 M61.82%
2009-12-31HK$18.5 M-55.52%
2008-12-31HK$41.59 M65.58%
2007-12-31HK$25.11 M28.38%
2006-12-31HK$19.56 M17.08%
2005-12-31HK$16.71 M82.73%
2004-12-31HK$9.14 M-66.31%
2003-12-31HK$27.14 M30.5%
2002-12-31HK$20.8 M30.73%
2001-12-31HK$15.91 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
HK$0.20 B-26.22%๐Ÿ‡บ๐Ÿ‡ธ USA